APO Research

APO RESEARCH · REPORT

Grass Pollen Allergy Drug

Selected research

Market Structure

Global Grass Pollen Allergy Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Grass Pollen Allergy Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Grass Pollen Allergy Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Grass Pollen Allergy Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Grass Pollen Allergy Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Grass Pollen Allergy Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Grass Pollen Allergy Drug include Roxall Medizin GmbH, HAL Allergy BV, Circassia Pharmaceuticals Plc, Biomay AG, Allergy Therapeutics Plc and ALK-Abello A/S, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Grass Pollen Allergy Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Grass Pollen Allergy Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Grass Pollen Allergy Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Grass Pollen Allergy Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Grass Pollen Allergy Drug Segment by Company

Roxall Medizin GmbH

HAL Allergy BV

Circassia Pharmaceuticals Plc

Biomay AG

Allergy Therapeutics Plc

ALK-Abello A/S

Grass Pollen Allergy Drug Segment by Type

BM-32

Pollinex Quattro Grass

Others

Grass Pollen Allergy Drug Segment by Application

Hospital

Research Center

Home Use

Grass Pollen Allergy Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Grass Pollen Allergy Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Grass Pollen Allergy Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Grass Pollen Allergy Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Grass Pollen Allergy Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Grass Pollen Allergy Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Grass Pollen Allergy Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Grass Pollen Allergy Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Grass Pollen Allergy Drug Industry Trends Table 2. Grass Pollen Allergy Drug Industry Drivers Table 3. Grass Pollen Allergy Drug Industry Opportunities and Challenges Table 4. Grass Pollen Allergy Drug Industry Restraints Table 5. Global Grass Pollen Allergy Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Grass Pollen Allergy Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Grass Pollen Allergy Drug Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Grass Pollen Allergy Drug Sales Market Share by Manufacturers Table 9. Global Grass Pollen Allergy Drug Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Grass Pollen Allergy Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Grass Pollen Allergy Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Grass Pollen Allergy Drug Manufacturers, Product Type & Application Table 13. Global Grass Pollen Allergy Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Grass Pollen Allergy Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of BM-32 Table 17. Major Manufacturers of Pollinex Quattro Grass Table 18. Major Manufacturers of Others Table 19. Global Grass Pollen Allergy Drug Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 20. Global Grass Pollen Allergy Drug Sales by Type (2021-2026) & (W Units) Table 21. Global Grass Pollen Allergy Drug Sales by Type (2027-2032) & (W Units) Table 22. Global Grass Pollen Allergy Drug Sales Market Share by Type (2021-2026) Table 23. Global Grass Pollen Allergy Drug Sales Market Share by Type (2027-2032) Table 24. Global Grass Pollen Allergy Drug Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 25. Global Grass Pollen Allergy Drug Revenue by Type (2021-2026) & (W Units) Table 26. Global Grass Pollen Allergy Drug Revenue by Type (2027-2032) & (W Units) Table 27. Global Grass Pollen Allergy Drug Revenue Market Share by Type (2021-2026) Table 28. Global Grass Pollen Allergy Drug Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Research Center Table 31. Major Manufacturers of Home Use Table 32. Global Grass Pollen Allergy Drug Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 33. Global Grass Pollen Allergy Drug Sales by Application (2021-2026) & (W Units) Table 34. Global Grass Pollen Allergy Drug Sales by Application (2027-2032) & (W Units) Table 35. Global Grass Pollen Allergy Drug Sales Market Share by Application (2021-2026) Table 36. Global Grass Pollen Allergy Drug Sales Market Share by Application (2027-2032) Table 37. Global Grass Pollen Allergy Drug Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 38. Global Grass Pollen Allergy Drug Revenue by Application (2021-2026) & (W Units) Table 39. Global Grass Pollen Allergy Drug Revenue by Application (2027-2032) & (W Units) Table 40. Global Grass Pollen Allergy Drug Revenue Market Share by Application (2021-2026) Table 41. Global Grass Pollen Allergy Drug Revenue Market Share by Application (2027-2032) Table 42. Global Grass Pollen Allergy Drug Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 43. Global Grass Pollen Allergy Drug Sales by Region (2021-2026) & (W Units) Table 44. Global Grass Pollen Allergy Drug Sales Market Share by Region (2021-2026) Table 45. Global Grass Pollen Allergy Drug Sales Forecasted by Region (2027-2032) & (W Units) Table 46. Global Grass Pollen Allergy Drug Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Grass Pollen Allergy Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 48. North America Grass Pollen Allergy Drug Sales by Country (2021-2026) & (W Units) Table 49. North America Grass Pollen Allergy Drug Sales by Country (2027-2032) & (W Units) Table 50. Europe Grass Pollen Allergy Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 51. Europe Grass Pollen Allergy Drug Sales by Country (2021-2026) & (W Units) Table 52. Europe Grass Pollen Allergy Drug Sales by Country (2027-2032) & (W Units) Table 53. Asia Pacific Grass Pollen Allergy Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 54. Asia Pacific Grass Pollen Allergy Drug Sales by Country (2021-2026) & (W Units) Table 55. Asia Pacific Grass Pollen Allergy Drug Sales by Country (2027-2032) & (W Units) Table 56. South America, Middle East and Africa Grass Pollen Allergy Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 57. South America, Middle East and Africa Grass Pollen Allergy Drug Sales by Country (2021-2026) & (W Units) Table 58. South America, Middle East and Africa Grass Pollen Allergy Drug Sales by Country (2027-2032) & (W Units) Table 59. Global Grass Pollen Allergy Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Grass Pollen Allergy Drug Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Grass Pollen Allergy Drug Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Grass Pollen Allergy Drug Revenue Market Share by Region (2021-2026) Table 63. Global Grass Pollen Allergy Drug Revenue Market Share by Region (2027-2032) Table 64. Roxall Medizin GmbH Company Information Table 65. Roxall Medizin GmbH Business Overview Table 66. Roxall Medizin GmbH Grass Pollen Allergy Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Roxall Medizin GmbH Grass Pollen Allergy Drug Product Portfolio Table 68. Roxall Medizin GmbH Recent Development Table 69. HAL Allergy BV Company Information Table 70. HAL Allergy BV Business Overview Table 71. HAL Allergy BV Grass Pollen Allergy Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. HAL Allergy BV Grass Pollen Allergy Drug Product Portfolio Table 73. HAL Allergy BV Recent Development Table 74. Circassia Pharmaceuticals Plc Company Information Table 75. Circassia Pharmaceuticals Plc Business Overview Table 76. Circassia Pharmaceuticals Plc Grass Pollen Allergy Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Circassia Pharmaceuticals Plc Grass Pollen Allergy Drug Product Portfolio Table 78. Circassia Pharmaceuticals Plc Recent Development Table 79. Biomay AG Company Information Table 80. Biomay AG Business Overview Table 81. Biomay AG Grass Pollen Allergy Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Biomay AG Grass Pollen Allergy Drug Product Portfolio Table 83. Biomay AG Recent Development Table 84. Allergy Therapeutics Plc Company Information Table 85. Allergy Therapeutics Plc Business Overview Table 86. Allergy Therapeutics Plc Grass Pollen Allergy Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Allergy Therapeutics Plc Grass Pollen Allergy Drug Product Portfolio Table 88. Allergy Therapeutics Plc Recent Development Table 89. ALK-Abello A/S Company Information Table 90. ALK-Abello A/S Business Overview Table 91. ALK-Abello A/S Grass Pollen Allergy Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. ALK-Abello A/S Grass Pollen Allergy Drug Product Portfolio Table 93. ALK-Abello A/S Recent Development Table 94. Key Raw Materials Table 95. Raw Materials Key Suppliers Table 96. Grass Pollen Allergy Drug Distributors List Table 97. Grass Pollen Allergy Drug Customers List Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Grass Pollen Allergy Drug Product Image Figure 2. Global Grass Pollen Allergy Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Grass Pollen Allergy Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Grass Pollen Allergy Drug Sales (2021-2032) & (W Units) Figure 5. Global Grass Pollen Allergy Drug Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Grass Pollen Allergy Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. BM-32 Image Figure 9. Pollinex Quattro Grass Image Figure 10. Others Image Figure 11. Global Grass Pollen Allergy Drug Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 12. Global Grass Pollen Allergy Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Grass Pollen Allergy Drug Sales Market Share by Type (2021-2032) Figure 14. Global Grass Pollen Allergy Drug Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 15. Global Grass Pollen Allergy Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Grass Pollen Allergy Drug Revenue Market Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Research Center Image Figure 19. Home Use Image Figure 20. Global Grass Pollen Allergy Drug Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 21. Global Grass Pollen Allergy Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Grass Pollen Allergy Drug Sales Market Share by Application (2021-2032) Figure 23. Global Grass Pollen Allergy Drug Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 24. Global Grass Pollen Allergy Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Grass Pollen Allergy Drug Revenue Market Share by Application (2021-2032) Figure 26. North America Grass Pollen Allergy Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 27. North America Grass Pollen Allergy Drug Sales Market Share by Country (2021-2032) Figure 28. U.S. Grass Pollen Allergy Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 29. Canada Grass Pollen Allergy Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 30. Mexico Grass Pollen Allergy Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 31. Europe Grass Pollen Allergy Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 32. Europe Grass Pollen Allergy Drug Sales Market Share by Country (2021-2032) Figure 33. Germany Grass Pollen Allergy Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 34. France Grass Pollen Allergy Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 35. U.K. Grass Pollen Allergy Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Italy Grass Pollen Allergy Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Netherlands Grass Pollen Allergy Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Asia Pacific Grass Pollen Allergy Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 39. Asia Pacific Grass Pollen Allergy Drug Sales Market Share by Country (2021-2032) Figure 40. China Grass Pollen Allergy Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Japan Grass Pollen Allergy Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 42. South Korea Grass Pollen Allergy Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Southeast Asia Grass Pollen Allergy Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 44. India Grass Pollen Allergy Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 45. Australia Grass Pollen Allergy Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 46. South America, Middle East and Africa Grass Pollen Allergy Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 47. South America, Middle East and Africa Grass Pollen Allergy Drug Sales Market Share by Country (2021-2032) Figure 48. Brazil Grass Pollen Allergy Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 49. South Africa Grass Pollen Allergy Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 50. Saudi Arabia Grass Pollen Allergy Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 51. Turkey Grass Pollen Allergy Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 52. Argentina Grass Pollen Allergy Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 53. UAE Grass Pollen Allergy Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Egypt Grass Pollen Allergy Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Chile Grass Pollen Allergy Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Global Grass Pollen Allergy Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Grass Pollen Allergy Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Grass Pollen Allergy Drug Revenue (2021-2032) & (US$ Million) Figure 59. North America Grass Pollen Allergy Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Grass Pollen Allergy Drug Revenue (2021-2032) & (US$ Million) Figure 61. Europe Grass Pollen Allergy Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Grass Pollen Allergy Drug Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Grass Pollen Allergy Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Grass Pollen Allergy Drug Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Grass Pollen Allergy Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Grass Pollen Allergy Drug Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Grass Pollen Allergy Drug Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • BM-32
  • Pollinex Quattro Grass
  • Others
Applications
  • Hospital
  • Research Center
  • Home Use
Companies covered
  • Roxall Medizin GmbH
  • HAL Allergy BV
  • Circassia Pharmaceuticals Plc
  • Biomay AG
  • Allergy Therapeutics Plc
  • ALK-Abello A/S

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Grass Pollen Allergy Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Grass Pollen Allergy Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Grass Pollen Allergy Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Grass Pollen Allergy Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Grass Pollen Allergy Drug Market Dynamics
  1. 2.1 Grass Pollen Allergy Drug Industry Trends
  2. 2.2 Grass Pollen Allergy Drug Industry Drivers
  3. 2.3 Grass Pollen Allergy Drug Industry Opportunities and Challenges
  4. 2.4 Grass Pollen Allergy Drug Industry Restraints
3 Grass Pollen Allergy Drug Market by Manufacturers
  1. 3.1 Global Grass Pollen Allergy Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Grass Pollen Allergy Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Grass Pollen Allergy Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Grass Pollen Allergy Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Grass Pollen Allergy Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Grass Pollen Allergy Drug Manufacturers, Product Type & Application
  7. 3.7 Global Grass Pollen Allergy Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Grass Pollen Allergy Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Grass Pollen Allergy Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Grass Pollen Allergy Drug Tier 1, Tier 2, and Tier 3
4 Grass Pollen Allergy Drug Market by Type
  1. 4.1 Grass Pollen Allergy Drug Type Introduction
  2. 4.1.1 BM-32
  3. 4.1.2 Pollinex Quattro Grass
  4. 4.1.3 Others
  5. 4.2 Global Grass Pollen Allergy Drug Sales by Type
  6. 4.2.1 Global Grass Pollen Allergy Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Grass Pollen Allergy Drug Sales by Type (2021-2032)
  8. 4.2.3 Global Grass Pollen Allergy Drug Sales Market Share by Type (2021-2032)
  9. 4.3 Global Grass Pollen Allergy Drug Revenue by Type
  10. 4.3.1 Global Grass Pollen Allergy Drug Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Grass Pollen Allergy Drug Revenue by Type (2021-2032)
  12. 4.3.3 Global Grass Pollen Allergy Drug Revenue Market Share by Type (2021-2032)
5 Grass Pollen Allergy Drug Market by Application
  1. 5.1 Grass Pollen Allergy Drug Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Research Center
  4. 5.1.3 Home Use
  5. 5.2 Global Grass Pollen Allergy Drug Sales by Application
  6. 5.2.1 Global Grass Pollen Allergy Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Grass Pollen Allergy Drug Sales by Application (2021-2032)
  8. 5.2.3 Global Grass Pollen Allergy Drug Sales Market Share by Application (2021-2032)
  9. 5.3 Global Grass Pollen Allergy Drug Revenue by Application
  10. 5.3.1 Global Grass Pollen Allergy Drug Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Grass Pollen Allergy Drug Revenue by Application (2021-2032)
  12. 5.3.3 Global Grass Pollen Allergy Drug Revenue Market Share by Application (2021-2032)
6 Global Grass Pollen Allergy Drug Sales by Region
  1. 6.1 Global Grass Pollen Allergy Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Grass Pollen Allergy Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Grass Pollen Allergy Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Grass Pollen Allergy Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Grass Pollen Allergy Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Grass Pollen Allergy Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Grass Pollen Allergy Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Grass Pollen Allergy Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Grass Pollen Allergy Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Grass Pollen Allergy Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Grass Pollen Allergy Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Grass Pollen Allergy Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Grass Pollen Allergy Drug Revenue by Region
  1. 7.1 Global Grass Pollen Allergy Drug Revenue by Region
  2. 7.1.1 Global Grass Pollen Allergy Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Grass Pollen Allergy Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Grass Pollen Allergy Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Grass Pollen Allergy Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Grass Pollen Allergy Drug Revenue (2021-2032)
  8. 7.2.2 North America Grass Pollen Allergy Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Grass Pollen Allergy Drug Revenue (2021-2032)
  11. 7.3.2 Europe Grass Pollen Allergy Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Grass Pollen Allergy Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Grass Pollen Allergy Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Grass Pollen Allergy Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Grass Pollen Allergy Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Roxall Medizin GmbH
  2. 8.1.1 Roxall Medizin GmbH Company Information
  3. 8.1.2 Roxall Medizin GmbH Business Overview
  4. 8.1.3 Roxall Medizin GmbH Grass Pollen Allergy Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Roxall Medizin GmbH Grass Pollen Allergy Drug Product Portfolio
  6. 8.1.5 Roxall Medizin GmbH Recent Developments
  7. 8.2 HAL Allergy BV
  8. 8.2.1 HAL Allergy BV Company Information
  9. 8.2.2 HAL Allergy BV Business Overview
  10. 8.2.3 HAL Allergy BV Grass Pollen Allergy Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 HAL Allergy BV Grass Pollen Allergy Drug Product Portfolio
  12. 8.2.5 HAL Allergy BV Recent Developments
  13. 8.3 Circassia Pharmaceuticals Plc
  14. 8.3.1 Circassia Pharmaceuticals Plc Company Information
  15. 8.3.2 Circassia Pharmaceuticals Plc Business Overview
  16. 8.3.3 Circassia Pharmaceuticals Plc Grass Pollen Allergy Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Circassia Pharmaceuticals Plc Grass Pollen Allergy Drug Product Portfolio
  18. 8.3.5 Circassia Pharmaceuticals Plc Recent Developments
  19. 8.4 Biomay AG
  20. 8.4.1 Biomay AG Company Information
  21. 8.4.2 Biomay AG Business Overview
  22. 8.4.3 Biomay AG Grass Pollen Allergy Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Biomay AG Grass Pollen Allergy Drug Product Portfolio
  24. 8.4.5 Biomay AG Recent Developments
  25. 8.5 Allergy Therapeutics Plc
  26. 8.5.1 Allergy Therapeutics Plc Company Information
  27. 8.5.2 Allergy Therapeutics Plc Business Overview
  28. 8.5.3 Allergy Therapeutics Plc Grass Pollen Allergy Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Allergy Therapeutics Plc Grass Pollen Allergy Drug Product Portfolio
  30. 8.5.5 Allergy Therapeutics Plc Recent Developments
  31. 8.6 ALK-Abello A/S
  32. 8.6.1 ALK-Abello A/S Company Information
  33. 8.6.2 ALK-Abello A/S Business Overview
  34. 8.6.3 ALK-Abello A/S Grass Pollen Allergy Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 ALK-Abello A/S Grass Pollen Allergy Drug Product Portfolio
  36. 8.6.5 ALK-Abello A/S Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Grass Pollen Allergy Drug Value Chain Analysis
  2. 9.1.1 Grass Pollen Allergy Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Grass Pollen Allergy Drug Production Mode & Process
  6. 9.2 Grass Pollen Allergy Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Grass Pollen Allergy Drug Distributors
  9. 9.2.3 Grass Pollen Allergy Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research